Zhirong Yang holds a bachelor degree in medicine and master degrees in epidemiology and in primary care. Before joining the Primary Care Unit in 2015, he worked successively as a biostatistician in Shantou-Oxford Clinical Research Unit and as a research associate in the Centre of Post-marketing Safety Evaluation within Peking University, mainly responsible for study design, data collection and analysis. Zhirong’s previous research projects focused on diabetes, cardiovascular diseases, tuberculosis, and skin and soft tissue diseases, involving evaluation of treatment effectiveness and safety, assessment of diagnostic test accuracy, exploration of environmental and genetic factors, and estimation of prevalence and incidence. As a clinical epidemiologist, Zhirong also contributed to methodological study of clinical research, promotion of reporting guidelines, and development of evidence-based clinical practice guidelines in China.
Zhirong’s current research interests are in the use of data from electronic health records and prospective cohort study to inform the management of cardiovascular diseases. Zhirong’s research project will be looking at Association of vascular risk factors and corresponding pharmacological modification treatments with post-stroke dementia with the Clinical Practice Research Datalink.
Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H, Zhan S. Interventions for treating gas gangrene. Cochrane Database of Systematic Reviews 2015; 12: CD010577.
Yang Z, Wang J, Wang W, Zhang Y, Han L, Zhang Y, Nie X, Zhan S. Proportions of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in patients with surgical site infections in mainland China: a systematic review and meta-analysis. PLoS ONE 2015; 10(1):e0116079.
Wu S, Xia Y, Lv X, Tang S, Yang Z, Zhang Y, Wang X, Hu D, Liu F, Yuan Y, Tu D, Sun F, Zhou L, Zhan S. Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients. Journal of Gastroenterology and Hepatology 2015; 30(3): 540-545.
Tang S, Lv X, Chen R, Wu S, Yang Z, Chen D, Zhan S. Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population. Clinical and Experimental Pharmacology and Physiology 2013; 40(5): 326-332.
Sun F, Yu K, Wu S, Zhang Y, Yang Z, Shi L, Ji L, Zhan S. Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: A pairwise and network meta-analysis. Diabetes Research and Clinical Practice 2012; 98(3): 386-395.
Sun F, Zeng X, Yang Z (editor). Explanation of reporting guidelines for medical research [in Chinese]. Beijing: Peking University Medical Press 2015.